No Growth Is Not the Whole Preservation Story

Start with a product that has already been used

In the northern Portuguese pharmacy survey, microorganisms were recovered from 25 of 42 cosmetic testers under the study's culture conditions. This is a finding about a particular regional sample, not a contamination probability for all cosmetics. Use frequency and replacement history were not measured.

A second number, 12 of 33, refers to characterised isolates meeting the study's operational multidrug-resistance definition. Products and isolates have different denominators. Antibiotic resistance is not preservative tolerance, and the survey did not demonstrate transmission or infection. Different genus-specific testing panels also limit comparisons.

Was a negative sample actually recoverable?

The survey did not neutralise residual preservative activity before culture. Antimicrobial conditions may therefore travel with the sample into the detection process. The authors explicitly caution that negative culture should not be interpreted as sterility.

That limitation does not tell us how many organisms were missed. It identifies an uncertainty, not a corrected contamination rate. A useful follow-up would validate both neutraliser effectiveness and neutraliser toxicity before interpreting recovery.

A botanical name is not the complete test material

The sugarcane-straw paper follows a different route: prepare extract-based combinations and evaluate specified culture and emulsion conditions. Those materials are not the pharmacy testers, so the second study cannot refute the first.

Solvents are part of the test system. Their contribution must be separated from that of the extract before attributing the overall result to botanical constituents. Composition, dissolution and the oil-water environment are relevant questions, but these two studies do not establish a complete causal chain from phase partitioning through a specific microbial target to use-stage protection.

Before comparing 5%, check the denominator

The sugarcane-straw paper describes the emulsion challenge addition as 5% v/v, whereas its conclusion uses 5% w/v. These expressions cannot simply be treated as interchangeable. The reported result for the tested emulsions and this unresolved concentration discrepancy must both remain visible.

A formulation team needs traceable composition, the mass or volume basis, actual addition and, where relevant, density and measured constituent content. A combination's addition level is not the amount of its effective constituents. This article does not convert the paper's conditions into a commercial recommendation.

A challenge result cannot represent every use scenario

A formula challenge follows behaviour after controlled inoculation. A tester survey asks what can be recovered at sampling. The two studies do not share a formula, exposure history or experimental design, and should not be presented as opposing arms of one experiment.

Packaging, repeated contact and storage are sensible variables for later investigation, not demonstrated causes of contamination in this comparison. Nor does emulsion type alone establish a universal risk ranking. Culture outcomes do not identify a molecular antimicrobial mechanism, and inhibition does not replace toxicological or irritation assessment.

Four different questions for the next experiments

First, test recovery: in a qualified microbiology laboratory, compare direct and neutralised processing at fixed sample and inoculum levels, with product-free recovery, neutraliser-toxicity and neutraliser-effectiveness controls. Measure viable counts and spike recovery. A toxic neutraliser or lack of reproducible recovery improvement would undermine the residual-inhibition explanation; low precision means uncertainty, not proof of equivalence.

Second, separate vehicle contribution: hold medium, strain and total addition constant while comparing matched base, vehicle and extract-containing combination. Measure viable-count trajectories after validated neutralisation. More surviving organisms, or disappearance of an apparent advantage after vehicle matching, would argue against an added extract contribution; a non-significant difference does not prove equivalence.

Third, measure constituent retention: compare fresh and stored target formulations at specified times and temperatures using calibrated chromatography, matrix blanks, spike recovery and independent preparation. A content decrease beyond predeclared analytical variation, once recovery is validated, would contradict retention. That chemical result alone does not determine antimicrobial performance.

Fourth, vary contact timing: in controlled laboratory conditions, hold formula, packaging and cumulative inoculum fixed while comparing single with divided inoculation. Follow viable counts and the post-contact decline using validated recovery. Higher or longer persistence in the repeated-contact group would limit transfer from the single challenge; no difference would still not establish equivalence across all real-world use. These are proposed studies, not completed experiments or consumer contamination tests.